Initiator Pharma A/S (STO:INIT)

Initiator Pharma Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	205	203	385	485	317	356
Market Cap Growth	-41.59%	-47.31%	-20.69%	52.80%	-10.94%	167.93%
Enterprise Value	187	163	366	475	268	318
Last Close Price	2.99	2.96	6.85	9.24	6.06	8.14
Forward PE	-	13.08	11.25	16.59	7.36	-
PB Ratio	7.75	4.73	16.93	29.13	6.23	7.36
P/TBV Ratio	7.75	4.73	16.93	29.13	6.23	7.36
Debt / Equity Ratio	0.42	0.07	-	1.38	0.37	0.38
Net Debt / Equity Ratio	-0.68	-0.82	-0.90	-0.80	-0.78	-0.60
Net Debt / EBITDA Ratio	-	-	-	-	0.64	0.91
Net Debt / FCF Ratio	0.47	1.36	1.11	0.50	0.81	0.62
Quick Ratio	20.69	14.71	15.02	9.34	26.54	7.10
Current Ratio	23.53	16.35	15.02	9.34	27.70	9.91
Return on Equity (ROE)	-149.95%	-61.75%	-99.69%	-101.24%	-111.44%	-85.27%
Return on Assets (ROA)	-83.31%	-44.82%	-39.73%	-43.24%	-51.13%	-41.61%
Return on Capital Employed (ROCE)	-104.10%	-56.10%	-98.10%	-101.60%	-89.60%	-47.80%
Earnings Yield	-16.20%	-9.79%	-5.17%	-7.04%	-18.15%	-8.18%
FCF Yield	-	-12.68%	-4.83%	-5.43%	-15.43%	-13.23%
Buyback Yield / Dilution	-	-12.00%	-6.12%	-8.47%	-37.72%	-28.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.